Colorectal Cancer
RSSArticles
-
Denosumab Use for the Practicing Oncologist
The U.S. Food and Drug Administration (FDA) has recently approved denosumab for the prevention of skeletal-related events in patients with bone metastases from solid tumors. -
Managing Influenza in Patients with Hematologic Malignancies
A 74-year retired veterinarian presents to the emergency department (ED) with shortness of breath. He was recently diagnosed with diffuse large-cell lymphoma with prominent abdominal lymphadenopathy and positive bone marrow and has been treated with two cycles of R-CHOP. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: GlaxoSmithKline Withdraws Lymerix: Company ‘Cuts Losses’ on Controversial Lyme Disease Vaccine
-
Subsite-Specific Incidence Rate And Stage Of Disease in Colorectal Cancer by Race, Gender, and Age Group in the United States
-
Risk of Lymph Node Metastasis in T1 Colorectal Carcinoma
-
Rehab joins with oncology to offer massage
-
Use of Surgical Procedures and Adjuvant Therapy in Rectal Cancer
-
Laparoscopic Colectomy for Cancer Offers Minimal Short-Term Benefit Over Open Colectomy
-
Antibody-Mediated Pure Red-Cell Aplasia in Patients Treated with Recombinant Erythropoietin